ReviewClinical interventions in aging2014

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause.

Gregory T Wurz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.